81_FR_34464 81 FR 34360 - Submission for OMB review; 30-day Comment Request; [email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication."> [email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication." /> [email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication." />

81 FR 34360 - Submission for OMB review; 30-day Comment Request;

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 104 (May 31, 2016)

Page Range34360-34361
FR Document2016-12726

In compliance with the requirement of Section 3507(a) (1) (D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection instrument listed below. This proposed information collection was previously published in the Federal Register on March 25, 2016, page 16190 and allowed 60-days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The NIH may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, [email protected] or by fax to 202-395-6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication.

Federal Register, Volume 81 Issue 104 (Tuesday, May 31, 2016) 
[Federal Register Volume 81, Number 104 (Tuesday, May 31, 2016)]
[Notices]
[Pages 34360-34361]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-12726]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB review; 30-day Comment Request;

    Request for Human Embryonic Stem Cell Line To Be Approved for Use 
in NIH Funded Research (OD)
SUMMARY: In compliance with the requirement of Section 3507(a) (1) (D) 
of the Paperwork Reduction Act of 1995, the National Institutes of 
Health (NIH) has submitted to the Office of Management and Budget (OMB) 
a request for review and approval of the information collection 
instrument listed below. This proposed information collection was 
previously published in the Federal Register on March 25, 2016, page 
16190 and allowed 60-days for public comment. No public comments were 
received. The purpose of this notice is to allow an additional 30 days 
for public comment. The NIH may not conduct or sponsor, and the 
respondent is not required to respond to, an information collection 
that has been extended, revised, or implemented on or after October 1, 
1995, unless it displays a currently valid OMB control number.
    Direct Comments to OMB: Written comments and/or suggestions 
regarding the item(s) contained in this notice, especially regarding 
the estimated public burden and associated response time, should be 
directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, [email protected] or by fax to 202-395-6974, 
Attention: NIH Desk Officer.
    Comment Due Date: Comments regarding this information collection 
are best assured of having their full effect if received within 30-days 
of the date of this publication.

FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data 
collection plans and instruments or request more information on the 
proposed project contact: Dr. Ellen Gadbois, Office of Science Policy, 
Office of the Director, NIH, Building 1, Room 218, MSC 0166, 9000 
Rockville Pike, Bethesda, MD 20892, or call non-toll-free number (301) 
496-9838 or Email your request, including your address to: 
[email protected]. Formal requests for additional plans and 
instruments must be requested in writing.
    Proposed Collection: Request for Human Embryonic Stem Cell Line to 
be approved for Use in NIH Funded Research. OMB No. 0925-0601- 
Expiration Date 5/31/2016--Extension- Office of Extramural Research 
(OER), National Institutes of Health (NIH).
    Need and Use of Information Collection: The form is used by 
applicants to request that human embryonic stem cell lines be approved 
for use in NIH funded research. Applicants may submit applications at 
any time.
    OMB approval is requested for 3 years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 2,550.

[[Page 34361]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Average time
               Type of respondent                    Number of     responses per  per response (   Total annual
                                                    respondents     respondent       in hours)      burden hour
----------------------------------------------------------------------------------------------------------------
NIH grantees and others with hESC lines.........              50               3              17           2,550
                                                 ---------------------------------------------------------------
    Total.......................................              50             150  ..............           2,550
----------------------------------------------------------------------------------------------------------------


    Dated: May 24, 2016.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2016-12726 Filed 5-27-16; 8:45 am]
 BILLING CODE 4140-01-P

34360 Federal Register / Vol. 81, No. 104 / Tuesday, May 31, 2016 / Notices This notice is being published less than 15 amended (5 U.S.C. App.), notice is has submitted to the Office of days prior to the meeting due to the timing hereby given of the following meeting. Management and Budget (OMB) a limitations imposed by the review and The meeting will be closed to the request for review and approval of the funding cycle. public in accordance with the information collection instrument listed Name of Committee: Allergy, Immunology, provisions set forth in sections below. This proposed information and Transplantation Research Committee. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., collection was previously published in Date: June 22–23, 2016, as amended. The contract proposals and the Federal Register on March 25, 2016, Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant the discussions could disclose page 16190 and allowed 60-days for applications. confidential trade secrets or commercial public comment. No public comments Place: National Institutes of Health, 4H100 property such as patentable material, were received. The purpose of this and 3C100, 5601 Fishers Lane, Rockville, MD and personal information concerning notice is to allow an additional 30 days 20892 (Telephone Conference Call). individuals associated with the contract for public comment. The NIH may not Contact Person: James T. Snyder, Ph.D., proposals, the disclosure of which conduct or sponsor, and the respondent Scientific Review Officer, Scientific Review would constitute a clearly unwarranted is not required to respond to, an Program, Division of Extramural Activities/ invasion of personal privacy. information collection that has been Room 3G31B, National Institutes of Health, Name of Committee: National Cancer extended, revised, or implemented on or NIAID, 5601 Fishers Lane MSC 9834, Bethesda, MD 20892–9834, (240) 669–5060, Institute Special Emphasis Panel after October 1, 1995, unless it displays james.snyder@nih.gov. Development of a Biosensor-Based Core a currently valid OMB control number. Needle Tumor Biopsy Device. Direct Comments to OMB: Written Name of Committee: National Institute of Date: June 2, 2016. Allergy and Infectious Diseases Special comments and/or suggestions regarding Time: 11:00 a.m. to 5:00 p.m. Emphasis Panel; NIAID Peer Review Meeting. Agenda: To review and evaluate contract the item(s) contained in this notice, Date: June 27–29, 2016. proposals. especially regarding the estimated Time: June 27, 2016, 8:00 a.m. to 5:00 p.m. Place: National Cancer Institute Shady public burden and associated response Agenda: To review and evaluate contract Grove 9609 Medical Center Drive, Room time, should be directed to the: Office proposals. 2W030, Rockville, MD 20850 (Telephone of Management and Budget, Office of Place: Hilton Washington/Rockville, Conference Call). Jefferson Room, 1750 Rockville Pike, Regulatory Affairs, OIRA_submission@ Contact Person: Kenneth L. Bielat, Ph.D., omb.eop.gov or by fax to 202–395–6974, Rockville, MD 20852. Scientific Review Officer, Research Time: June 28, 2016, 8:00 a.m. to 5:00 p.m. Technology and Contract Review Branch, Attention: NIH Desk Officer. Agenda: To review and evaluate contract Division of Extramural Activities, National Comment Due Date: Comments proposals. Cancer Institute, 9609 Medical Center Drive, regarding this information collection are Place: Hilton Washington/Rockville, Room 7W244, Rockville, MD 20892–9750, best assured of having their full effect if Jefferson Room, 1750 Rockville Pike, 240–276–6373, bielatk@mail.nih.gov. received within 30-days of the date of Rockville, MD 20852. This notice is being published less than 15 this publication. Time: June 29, 2016, 8:00 a.m. to 2:00 p.m. days prior to the meeting due to the timing Agenda: To review and evaluate contract limitations imposed by the review and FOR FURTHER INFORMATION CONTACT: To proposals. funding cycle. obtain a copy of the data collection Place: Hilton Washington/Rockville, (Catalogue of Federal Domestic Assistance plans and instruments or request more Jefferson Room, 1750 Rockville Pike, Program Nos. 93.392, Cancer Construction; information on the proposed project Rockville, MD 20852. 93.393, Cancer Cause and Prevention contact: Dr. Ellen Gadbois, Office of Contact Person: Nancy Vazquez- Research; 93.394, Cancer Detection and Maldonado, Ph.D., Scientific Review Officer, Science Policy, Office of the Director, Diagnosis Research; 93.395, Cancer NIH, Building 1, Room 218, MSC 0166, Scientific Review Program, Division of Treatment Research; 93.396, Cancer Biology Extramural Activities, Room 3F52B National 9000 Rockville Pike, Bethesda, MD Research; 93.397, Cancer Centers Support; Institutes of Health/NIAID, 5601 Fishers 93.398, Cancer Research Manpower; 93.399, 20892, or call non-toll-free number (301) Lane, MSC 9834, Bethesda, MD 20892–9834, Cancer Control, National Institutes of Health, 496–9838 or Email your request, (240) 669–5044, nvazquez@niaid.nih.gov. HHS). including your address to: gadboisel@ (Catalogue of Federal Domestic Assistance od.nih.gov. Formal requests for Dated: May 24, 2016. Program Nos. 93.855, Allergy, Immunology, additional plans and instruments must and Transplantation Research; 93.856, Melanie J. Gray, be requested in writing. Microbiology and Infectious Diseases Program Analyst, Office of Federal Advisory Research, National Institutes of Health, HHS). Committee Policy. Proposed Collection: Request for [FR Doc. 2016–12662 Filed 5–27–16; 8:45 am] Human Embryonic Stem Cell Line to be Dated: May 24, 2016. approved for Use in NIH Funded Natasha M. Copeland, BILLING CODE 4140–01–P Research. OMB No. 0925–0601- Program Analyst, Office of Federal Advisory Expiration Date 5/31/2016—Extension- Committee Policy. Office of Extramural Research (OER), DEPARTMENT OF HEALTH AND [FR Doc. 2016–12649 Filed 5–27–16; 8:45 am] National Institutes of Health (NIH). HUMAN SERVICES BILLING CODE 4140–01–P Need and Use of Information National Institutes of Health Collection: The form is used by applicants to request that human DEPARTMENT OF HEALTH AND Submission for OMB review; 30-day embryonic stem cell lines be approved HUMAN SERVICES Comment Request; for use in NIH funded research. Request for Human Embryonic Stem Applicants may submit applications at sradovich on DSK3TPTVN1PROD with NOTICES National Institutes of Health Cell Line To Be Approved for Use in any time. National Cancer Institute; Notice of NIH Funded Research (OD) OMB approval is requested for 3 Closed Meetings SUMMARY: In compliance with the years. There are no costs to respondents requirement of Section 3507(a) (1) (D) of other than their time. The total Pursuant to section 10(d) of the the Paperwork Reduction Act of 1995, estimated annualized burden hours are Federal Advisory Committee Act, as the National Institutes of Health (NIH) 2,550. VerDate Sep<11>2014 20:07 May 27, 2016 Jkt 238001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\31MYN1.SGM 31MYN1

Federal Register / Vol. 81, No. 104 / Tuesday, May 31, 2016 / Notices 34361 ESTIMATED ANNUALIZED BURDEN HOURS Number of Average time Type of Number of Total annual responses per per response respondent respondents burden hour respondent ( in hours) NIH grantees and others with hESC lines ....................................................... 50 3 17 2,550 Total .......................................................................................................... 50 150 ........................ 2,550 Dated: May 24, 2016. Boulevard, Rockville, MD 20852 (Telephone Name of Committee: Interdisciplinary Lawrence A. Tabak, Conference Call). Molecular Sciences and Training Integrated Contact Person: Lyle Furr, Scientific Review Group; Enabling Bioanalytical and Deputy Director, National Institutes of Health. Review Officer, Office of Extramural Affairs, Imaging Technologies Study Section. [FR Doc. 2016–12726 Filed 5–27–16; 8:45 am] National Institute on Drug Abuse, NIH, Date: June 23–24, 2016. BILLING CODE 4140–01–P DHHS, Room 4227, MSC 9550, 6001 Time: 8:00 a.m. to 6:00 p.m. Executive Boulevard, Bethesda, MD 20892– Agenda: To review and evaluate grant 9550, (301) 435–1439, lf33c.nih.gov. applications. DEPARTMENT OF HEALTH AND (Catalogue of Federal Domestic Assistance Place: Hotel Kabuki, 1625 Post Street, San HUMAN SERVICES Program No.: 93.279, Drug Abuse and Francisco, CA 94115. Addiction Research Programs, National Contact Person: Kenneth Ryan, Ph.D., National Institutes of Health Institutes of Health, HHS). Scientific Review Officer, Center for Dated: May 24, 2016. Scientific Review, National Institutes of National Institute on Drug Abuse; Natasha M. Copeland, Health, 6701 Rockledge Drive, Room 3218, Notice of Closed Meeting MSC 7717, Bethesda, MD 20892, 301–435– Program Analyst, Office of Federal Advisory 0229, kenneth.ryan@nih.hhs.gov. Pursuant to section 10(d) of the Committee Policy. Name of Committee: Oncology 2— Federal Advisory Committee Act, as [FR Doc. 2016–12647 Filed 5–27–16; 8:45 am] Translational Clinical Integrated Review amended BILLING CODE 4140–01–P Group;Cancer Immunopathology and (5 U.S.C. App), notice is hereby given Immunotherapy Study Section. Date: June 23–24, 2016. of the following meeting. DEPARTMENT OF HEALTH AND Time: 8:00 a.m. to 1:00 p.m. The meeting will be closed to the HUMAN SERVICES Agenda: To review and evaluate grant public in accordance with the applications. provisions set forth in sections National Institutes of Health Place: The Embassy Row Hotel, 2015 552b(c)(4) and 552b(c)(6), title 5 U.S.C., Massachusetts Avenue NW., Washington, DC as amended. The contract proposals and Center for Scientific Review; Notice of 20036. the discussions could disclose Closed Meetings Contact Person: Denise R. Shaw, Ph.D., confidential trade secrets or commercial Scientific Review Officer, Center for Pursuant to section 10(d) of the Scientific Review, National Institutes of property such as patentable material, Federal Advisory Committee Act, as Health, 6701 Rockledge Drive, Room 6158, and personal information concerning amended (5 U.S.C. App.), notice is MSC 7804, Bethesda, MD 20892, 301–435– individuals associated with the contract hereby given of the following meetings. 0198, shawdeni@csr.nih.gov. proposals, the disclosure of which The meetings will be closed to the Name of Committee: Center for Scientific would constitute a clearly unwarranted public in accordance with the Review Special Emphasis Panel; Review of invasion of personal privacy. provisions set forth in sections Neuroscience AREA Grant Applications. Name of Committee: National Institute on 552b(c)(4) and 552b(c)(6), title 5 U.S.C., Date: June 23–24, 2016. Drug Abuse Special Emphasis Panel; as amended. The grant applications and Time: 8:00 a.m. to 1:00 p.m. Synthesis and Distribution of Opioid and the discussions could disclose Agenda: To review and evaluate grant Related Peptides (7795). applications. confidential trade secrets or commercial Date: June 28, 2016. Place: DoubleTree by Hilton, 1515 Rhode property such as patentable material, Island Avenue NW., Washington, DC 20005. Time: 10:00 a.m. to 12:00 p.m. Agenda: To review and evaluate contract and personal information concerning Contact Person: Richard D. Crosland, proposals. individuals associated with the grant Ph.D., Scientific Review Officer, Center for Place: National Institutes of Health, applications, the disclosure of which Scientific Review, National Institutes of Neuroscience Center, 6001 Executive would constitute a clearly unwarranted Health, 6701 Rockledge Drive, Room 4190, Boulevard, Rockville, MD 20852 (Telephone invasion of personal privacy. MSC 7850, Bethesda, MD 20892, 301–435– Conference Call). 1220, crosland@nih.gov. Name of Committee: Center for Scientific Contact Person: Lyle Furr, Scientific Review Special Emphasis Panel; Member Name of Committee: Center for Scientific Review Officer, Office of Extramural Affairs, Conflict: CVRS New Investigator. Review Special Emphasis Panel; Small National Institute on Drug Abuse, NIH, Date: June 22, 2016. Business: Biomedical Sensing, Measurement DHHS, Room 4227, MSC 9550, 6001 Time: 10:00 a.m. to 12:00 p.m. and Instrumentation. Executive Boulevard, Bethesda, MD 20892– Agenda: To review and evaluate grant Date: June 24, 2016. 9550, (301) 435–1439, lf33c.nih.gov. applications. Time: 8:00 a.m. to 5:00 p.m. Name of Committee: National Institute on Place: National Institutes of Health, 6701 Agenda: To review and evaluate grant sradovich on DSK3TPTVN1PROD with NOTICES Drug Abuse Special Emphasis Panel; Non- Rockledge Drive, Bethesda, MD 20892 applications. Clinical ADME Studies (8931). (Telephone Conference Call). Place: Hilton Washington/Rockville, 1750 Date: July 13, 2016. Contact Person: Margaret Chandler, Ph.D., Rockville Pike, Rockville, MD 20852. Time: 10:00 a.m. to 12:00 p.m. Scientific Review Officer, Center for Contact Person: Inna Gorshkova, Ph.D., Agenda: To review and evaluate contract Scientific Review, National Institutes of Scientific Review Officer, Center for proposals. Health, 6701 Rockledge Drive, Room 4126, Scientific Review, National Institutes of Place: National Institutes of Health, MSC 7814, Bethesda, MD 20892, (301435– Health, 6701 Rockledge Drive, Bethesda, MD Neuroscience Center, 6001 Executive 1743, margaret.chandler@nih.gov. 20892, 301–435–1784, gorshkoi@csr.nih.gov. VerDate Sep<11>2014 20:07 May 27, 2016 Jkt 238001 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\31MYN1.SGM 31MYN1


Document Created: 2016-05-28 03:57:23
Document Modified: 2016-05-28 03:57:23
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesComments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication.
ContactTo obtain a copy of the data collection plans and instruments or request more information on the proposed project contact: Dr. Ellen Gadbois, Office of Science Policy, Office of the Director, NIH, Building 1, Room 218, MSC 0166, 9000 Rockville Pike, Bethesda, MD 20892, or call non-toll-free number (301)
FR Citation81 FR 34360 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR